Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists

@inproceedings{Shakespeare2015EffectOP,
  title={Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists},
  author={Thomas Philip Shakespeare},
  booktitle={Radiation oncology},
  year={2015}
}
BACKGROUND Positron emission tomography (PET) imaging is routinely used in many cancer types, although is not yet a standard modality for prostate carcinoma. Prostate-specific membrane antigen (PSMA) PET is a promising new modality for staging prostate cancer, with recent studies showing potential advantages over traditional computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine bone scan imaging. However, the impact of PSMA PET on the decision-making of radiation… CONTINUE READING